Stabilizing formulations for recombinant viruses

Details for Australian Patent Application No. 2006315026 (hide)

Owner Sanofi Pasteur Limited

Inventors Cigarini, Sandrine

Agent Spruson & Ferguson

Pub. Number AU-A-2006315026

PCT Pub. Number WO2007/056847

Priority 60/597,280 21.11.05 US

Filing date 15 November 2006

Wipo publication date 24 May 2007

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 1/04 (2006.01) Micro-organisms, e.g. protozoa - Preserving or maintaining viable micro-organisms

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056847 Priority application(s): WO2007/056847

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315034-Apparatus and method for conducting remote video inspection from above

2006315025-Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase